BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20145206)

  • 1. Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells.
    Dressel R; Nolte J; Elsner L; Novota P; Guan K; Streckfuss-Bömeke K; Hasenfuss G; Jaenisch R; Engel W
    FASEB J; 2010 Jul; 24(7):2164-77. PubMed ID: 20145206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.
    Dressel R; Guan K; Nolte J; Elsner L; Monecke S; Nayernia K; Hasenfuss G; Engel W
    Biol Direct; 2009 Aug; 4():31. PubMed ID: 19715575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Killing of Murine Pluripotent Stem Cells by Natural Killer (NK) Cells Requires Activation by Cytokines and Partly Depends on the Activating NK Receptor NKG2D.
    Gröschel C; Hübscher D; Nolte J; Monecke S; Sasse A; Elsner L; Paulus W; Trenkwalder C; Polić B; Mansouri A; Guan K; Dressel R
    Front Immunol; 2017; 8():870. PubMed ID: 28890717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1.
    Kruse V; Hamann C; Monecke S; Cyganek L; Elsner L; Hübscher D; Walter L; Streckfuss-Bömeke K; Guan K; Dressel R
    PLoS One; 2015; 10(5):e0125544. PubMed ID: 25950680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential role of natural killer group 2D in recognition and cytotoxicity of hepatocyte-like cells derived from embryonic stem cells and induced pluripotent stem cells.
    Cisneros T; Dillard DW; Qu X; Arredondo-Guerrero J; Castro M; Schaffert S; Martin R; Esquivel CO; Krams SM; Martinez OM
    Am J Transplant; 2019 Jun; 19(6):1652-1662. PubMed ID: 30549427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell subsets differentially reject embryonic stem cells based on licensing.
    Perez-Cunningham J; Ames E; Smith RC; Peter AK; Naidu R; Nolta JA; Murphy WJ
    Transplantation; 2014 May; 97(10):992-8. PubMed ID: 24704665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes.
    Frenzel LP; Abdullah Z; Kriegeskorte AK; Dieterich R; Lange N; Busch DH; Krönke M; Utermöhlen O; Hescheler J; Sarić T
    Stem Cells; 2009 Feb; 27(2):307-16. PubMed ID: 18988711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium.
    Swijnenburg RJ; Tanaka M; Vogel H; Baker J; Kofidis T; Gunawan F; Lebl DR; Caffarelli AD; de Bruin JL; Fedoseyeva EV; Robbins RC
    Circulation; 2005 Aug; 112(9 Suppl):I166-72. PubMed ID: 16159810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Killer Cells Prevent the Formation of Teratomas Derived From Human Induced Pluripotent Stem Cells.
    Benabdallah B; Désaulniers-Langevin C; Colas C; Li Y; Rousseau G; Guimond JV; Haddad E; Beauséjour C
    Front Immunol; 2019; 10():2580. PubMed ID: 31787975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological Properties of Murine Parthenogenetic Stem Cells and Their Differentiation Products.
    Johannsen H; Muppala V; Gröschel C; Monecke S; Elsner L; Didié M; Zimmermann WH; Dressel R
    Front Immunol; 2017; 8():924. PubMed ID: 28824647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
    Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
    Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
    Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
    Front Immunol; 2020; 11():1534. PubMed ID: 32849519
    [No Abstract]   [Full Text] [Related]  

  • 13. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
    El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
    Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
    Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
    Front Immunol; 2020; 11():40. PubMed ID: 32082316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade.
    Koh CY; Ortaldo JR; Blazar BR; Bennett M; Murphy WJ
    Blood; 2003 Dec; 102(12):4067-75. PubMed ID: 12893752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.
    Boerman GH; van Ostaijen-ten Dam MM; Kraal KC; Santos SJ; Ball LM; Lankester AC; Schilham MW; Egeler RM; van Tol MJ
    Cancer Immunol Immunother; 2015 May; 64(5):573-83. PubMed ID: 25854581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Tumorigenicity of Multipotent Adult Germline Stem Cells Transplanted into the Heart Is Affected by Natural Killer Cells and by Cyclosporine A Independent of Its Immunosuppressive Effects.
    Hübscher D; Kaiser D; Elsner L; Monecke S; Dressel R; Guan K
    Front Immunol; 2017; 8():67. PubMed ID: 28220117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering human pluripotent stem cell lines to evade xenogeneic transplantation barriers.
    Pizzato HA; Alonso-Guallart P; Woods J; Connelly JP; Fehniger TA; Atkinson JP; Pruett-Miller SM; Monsma FJ; Bhattacharya D
    Stem Cell Reports; 2024 Feb; 19(2):299-313. PubMed ID: 38215755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
    Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC
    Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response.
    Dressel R; Schindehütte J; Kuhlmann T; Elsner L; Novota P; Baier PC; Schillert A; Bickeböller H; Herrmann T; Trenkwalder C; Paulus W; Mansouri A
    PLoS One; 2008 Jul; 3(7):e2622. PubMed ID: 18612432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.